Atiprosin

Immunogen 18 amino acids near the carboxy terminus of human ATG9A. Application Used as a blocking peptide in immunoblotting applications.

Immunogen 17 amino acids near the carboxy terminus of human ATG9B. Application Used as a blocking peptide in immunoblotting applications.

Biochem/physiol Actions ATI-2341 is a potent and selective allosteric agonist of chemokine CXC-type receptor 4 (CXCR4) that functions as a biased ligand, favoring G&#945:i activation over G&#945:13. ATI-2341 does not promote &#946:-arrestin

General description Atrasentan has also been used to treat cardiovascular disease. Biochem/physiol Actions Atrasentan is a selective endothelin ETA receptor antagonist with an IC50 of 0.

General description Atrasentan has also been used to treat cardiovascular disease. Biochem/physiol Actions Atrasentan is a selective endothelin ETA receptor antagonist with an IC50 of 0.

Atriopeptin is a 28 amino acid peptide synthesized primarily in cardiac atria. This peptide hormone acts in opposition to angiotensin II in regulating renal, hemodynamic, and endocrine function.

Immunogen 14 amino acids near the carboxy terminus of human AXIN1. Application Used as a blocking peptide in immunoblotting applications.

The a1-adrenergic receptor (AR) family consists of three closely related gene products (a_1A, a_1B, and a_1D) that mediate the actions of norepinephrine (NE) and epinephrine in sympathetically innervated tissues and

Atrial natriuretic peptide (ANP) is a cardiomodulatory peptide that binds the natriuretic peptide receptor type A (NPR-A), increasing levels of cGMP and activating cGMP-dependent kinases. ANP exhibits vasodilatory/hypotensive, diuretic, and

Atrial natriuretic peptide (ANP) is a cardiomodulatory peptide that binds the natriuretic peptide receptor type A (NPR-A), increasing levels of cGMP and activating cGMP-dependent kinases. ANP exhibits vasodilatory/hypotensive, diuretic, and

Atrial natriuretic peptide (ANP) is a cardiomodulatory peptide that binds the natriuretic peptide receptor type A (NPR-A), increasing levels of cGMP and activating cGMP-dependent kinases. ANP exhibits vasodilatory/hypotensive, diuretic, and

Atrial natriuretic peptide (ANP) is a cardiomodulatory peptide that binds the natriuretic peptide receptor type A (NPR-A), increasing levels of cGMP and activating cGMP-dependent kinases. ANP exhibits vasodilatory/hypotensive, diuretic, and